PT2833899T - Composições compreendendo coquetéis de fagos e uso das mesmas para o tratamento de infeções bacterianas - Google Patents

Composições compreendendo coquetéis de fagos e uso das mesmas para o tratamento de infeções bacterianas

Info

Publication number
PT2833899T
PT2833899T PT137254967T PT13725496T PT2833899T PT 2833899 T PT2833899 T PT 2833899T PT 137254967 T PT137254967 T PT 137254967T PT 13725496 T PT13725496 T PT 13725496T PT 2833899 T PT2833899 T PT 2833899T
Authority
PT
Portugal
Prior art keywords
cocktails
compositions
treatment
bacterial infections
phages
Prior art date
Application number
PT137254967T
Other languages
English (en)
Original Assignee
Technophage Investig E Desenvolvimento Em Biotecnologia Sa
Tecnifar Ind Tecnica Farmaceutica S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Technophage Investig E Desenvolvimento Em Biotecnologia Sa, Tecnifar Ind Tecnica Farmaceutica S A filed Critical Technophage Investig E Desenvolvimento Em Biotecnologia Sa
Publication of PT2833899T publication Critical patent/PT2833899T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/32—Surgical cutting instruments
    • A61B17/3205—Excision instruments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/503—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/32—Surgical cutting instruments
    • A61B2017/320004—Surgical cutting instruments abrasive
    • A61B2017/320008—Scrapers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Surgery (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Obesity (AREA)
PT137254967T 2012-03-19 2013-03-19 Composições compreendendo coquetéis de fagos e uso das mesmas para o tratamento de infeções bacterianas PT2833899T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261612531P 2012-03-19 2012-03-19

Publications (1)

Publication Number Publication Date
PT2833899T true PT2833899T (pt) 2020-09-15

Family

ID=48534472

Family Applications (1)

Application Number Title Priority Date Filing Date
PT137254967T PT2833899T (pt) 2012-03-19 2013-03-19 Composições compreendendo coquetéis de fagos e uso das mesmas para o tratamento de infeções bacterianas

Country Status (14)

Country Link
US (1) US9962419B2 (pt)
EP (1) EP2833899B1 (pt)
JP (1) JP6186427B2 (pt)
CN (1) CN104519893B (pt)
AU (1) AU2013235883B2 (pt)
BR (1) BR112014023321B1 (pt)
CA (1) CA2867418C (pt)
DK (1) DK2833899T3 (pt)
ES (1) ES2814024T3 (pt)
HK (1) HK1207002A1 (pt)
PT (1) PT2833899T (pt)
RU (1) RU2654596C2 (pt)
SG (1) SG11201405829WA (pt)
WO (1) WO2013141730A1 (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2865383A1 (en) * 2013-10-25 2015-04-29 Pherecydes Pharma Phage therapy of pseudomonas infections
WO2016066722A2 (en) * 2014-10-28 2016-05-06 Ian Humphery-Smith Bacteriophage combinations for human or animal therapy
US10455983B2 (en) 2015-09-10 2019-10-29 Prince Castle LLC Modular food holding system
US20170157186A1 (en) * 2015-12-02 2017-06-08 Smart Phage, Inc. Phage to treat bacteria on skin
US11554158B2 (en) 2016-04-13 2023-01-17 Northeast Ohio Medical University GPNMB compositions for treatment of skin wounds
US11672839B2 (en) 2016-12-05 2023-06-13 Technechnophage, Investigacao E Desenvolvimento Em Biotecnologia, Sa Bacteriophage compositions comprising respiratory antibacterial phages and methods of use thereof
CA3074655A1 (en) * 2017-09-05 2019-03-14 Adaptive Phage Therapeutics, Inc. Methods to determine the sensitivity profile of a bacterial strain to a therapeutic composition
CA3079544A1 (en) * 2017-10-19 2019-04-25 Mona E. Buice Topical composition for improved healing of open wounds
PT3724886T (pt) 2017-12-11 2023-01-06 Adaptive Phage Therapeutics Inc Sistema de distribuição de fagos
US11654166B2 (en) 2018-01-02 2023-05-23 Armata Pharmaceuticals, Inc. Therapeutic bacteriophage compositions for treating Staphylococcus infection
CN109082414B (zh) * 2018-06-29 2020-11-13 浙江工业大学 一种金黄色葡萄球菌噬菌体及应用
JP2021530244A (ja) 2018-07-24 2021-11-11 メディミューン，エルエルシー Ｓ．アウレウス（Ｓ．ａｕｒｅｕｓ）クランピング因子Ａ（ＣｌｆＡ）に対する抗体
CN109730235A (zh) * 2019-02-01 2019-05-10 珠海横琴普罗恩能医用食品有限公司 一种用于医用食品的防腐剂
WO2020237044A1 (en) * 2019-05-21 2020-11-26 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Bacteriophages for the treatment of tuberculosis
CN111643724B (zh) * 2020-07-01 2022-01-28 南京大学 一种载有噬菌体和酸性成纤维细胞生长因子的水凝胶伤口敷料的制备方法及其应用
WO2022013314A1 (en) 2020-07-14 2022-01-20 Biontech R&D (Austria) Gmbh Bacteriophage cocktails and uses thereof
WO2022013318A1 (en) 2020-07-14 2022-01-20 Biontech R&D (Austria) Gmbh New mosaic bacteriophages and uses thereof
CN112251439B (zh) * 2020-10-26 2022-06-21 齐鲁师范学院 拟南芥高温诱导启动子pHTG1及其重组载体
CN112301001B (zh) * 2020-11-03 2022-10-14 华中农业大学 金黄色葡萄球菌噬菌体lsa2311及其应用
CN113201458B (zh) * 2020-12-21 2022-05-27 青岛诺安百特生物技术有限公司 一种提高噬菌体制剂稳定性的组合物及其应用
AU2022272135A1 (en) * 2021-05-12 2024-01-04 Biomx Ltd. Staphylococcus bacteriophage and uses thereof
DE202022102100U1 (de) 2022-04-20 2022-04-27 Prabhakar Ramesh Bhandari Synergistische antibiotische pharmazeutische Zusammensetzung zur Behandlung von Staphylococcus aureus-Infektionen
WO2024115430A1 (en) * 2022-11-28 2024-06-06 Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Acinetobacter baumannii phages

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995027043A1 (en) 1994-04-05 1995-10-12 Exponential Biotherapies, Inc. Antibacterial therapy with genotypically modified bacteriophage
US5863560A (en) 1996-09-11 1999-01-26 Virotex Corporation Compositions and methods for topical application of therapeutic agents
US6138401A (en) 1999-06-25 2000-10-31 Duncan; Franklin R. Fish hook remover
CA2479897A1 (en) * 2002-03-25 2003-10-02 David Allan Hodgson Bacteriophages useful for therapy and prophylaxis of bacterial infections
US20050095222A1 (en) 2003-10-29 2005-05-05 Taro Suzuki Allergen inhibitor, allergen-inhibiting method, allergen-inhibiting fiber and allergen-inhibiting sheet
AU2005301048A1 (en) 2004-11-02 2006-05-11 Chr. Hansen A/S Bacteriophage compositions
DK1812025T3 (da) 2004-11-02 2012-10-22 Chr Hansen As Stabiliserede bakteriofagformuleringer
CA2593992A1 (en) 2004-12-06 2006-06-15 Rodney M. Donlan Inhibition of biofilm formation using bacteriophage
CA2609357A1 (en) 2005-05-26 2006-11-30 Gangagen Life Sciences Inc. Bacterial management in animal holding systems
CN105456300B (zh) 2009-02-06 2019-07-09 抗菌技术,生物技术研究与发展股份有限公司 抗菌噬菌体、噬菌体肽及其使用方法
PT104837A (pt) 2009-11-24 2011-05-24 Technophage Investiga O E Desenvolvimento Em Biotecnologia S A P?ptidos de fagos enteroc?cicos e m?todos para a sua utiliza??o
JP6058540B2 (ja) * 2010-09-17 2017-01-11 テクニファー−インダストリア テクニカ ファーマシューティカ，エス．エー． 抗菌性ファージ、ファージペプチド、及びそれらの使用方法

Also Published As

Publication number Publication date
US9962419B2 (en) 2018-05-08
BR112014023321A2 (pt) 2022-02-01
CA2867418A1 (en) 2013-09-26
CN104519893A (zh) 2015-04-15
AU2013235883A1 (en) 2014-10-02
EP2833899B1 (en) 2020-06-24
US20150150919A1 (en) 2015-06-04
AU2013235883B2 (en) 2018-01-04
SG11201405829WA (en) 2014-10-30
CN104519893B (zh) 2020-02-07
WO2013141730A1 (en) 2013-09-26
JP6186427B2 (ja) 2017-08-23
RU2654596C2 (ru) 2018-05-21
RU2014141941A (ru) 2016-05-20
HK1207002A1 (en) 2016-01-22
ES2814024T3 (es) 2021-03-25
JP2015512384A (ja) 2015-04-27
CA2867418C (en) 2020-03-10
BR112014023321B1 (pt) 2022-06-14
EP2833899A1 (en) 2015-02-11
DK2833899T3 (da) 2020-09-28

Similar Documents

Publication Publication Date Title
HK1207002A1 (en) Compositions comprising cocktails of antibacterial phages and uses thereof for the treatment of bacterial infections
HK1222398A1 (zh) 治療伯克霍爾德氏菌感染症的組合物及方法
SI2627334T1 (sl) Sestavki za uporabo pri zdravljenju virusnih infekcij
HK1205696A1 (en) Compositions for topical treatment of microbial infections
HK1210018A1 (en) Tailored liposomes for the treatment of bacterial infections
EP2761029A4 (en) NOVEL BACTERIOPHAGE AND ANTIBACTERIAL COMPOSITION THEREWITH
PL2696890T3 (pl) Leczenie infekcji drobnoustrojowych
EP2655603A4 (en) NOVEL BACTERIOPHAGE AND ANTIBACTERIAL COMPOSITION THEREWITH
GB201217097D0 (en) Treatment of bacterial infection
HRP20160150T1 (en) Treatment of streptococcal infections
AP2015008338A0 (en) Compounds for the treatment and prevention of retroviral infections
HK1202539A1 (en) (r) -nifuratel, its use for the treatment of infections and synthesis of (r) and (s) -nifuratel (r)-(r)(s)-
IL233486A0 (en) Synthetic peptides for the treatment of bacterial infections
HK1207981A1 (en) Methods of treating and preventing staphylococcus aureus infections and associated conditions
ZA201503474B (en) Compositions and methods for treating bacterial infections
EP2969003A4 (en) METHOD AND COMPOSITIONS FOR BACTERIAL INFECTIONS
EP2844258A4 (en) METHOD AND COMPOSITIONS FOR TREATING BACTERIAL INFECTIONS
EP2916653A4 (en) ANTIBIOTIC METHODS AND ANTIBIOTIC COMPOSITIONS FOR BACTERIAL INFECTIONS
EP2906216A4 (en) INHIBITORS OF THE DNA GYRASE FOR THE TREATMENT OF BACTERIAL INFECTIONS
HK1175786A1 (en) Synthetic lta mimetics and use thereof as vaccine component for therapy and/or prophylaxis against gram-positive infections lta /
PL2862576T3 (pl) Drobnoustroje i zawierające je kompozycje do stosowania do leczenia lub profilaktyki zapalenia sutka
EP2529728A4 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF BACTERIAL INFECTIONS
EP2772248A4 (en) PHARMACEUTICAL COMPOSITION AND KIT FOR THE TREATMENT OF BACTERIAL INFECTIONS
EP2665738A4 (en) COMPOUNDS FOR TREATING BACTERIAL INFECTION
EP2670407A4 (en) TREATMENT OF BACTERIAL INFECTIONS